<p>(A) Expression of CD79a on immature myeloid cells (characterized as CD11b<sup>+</sup>CD33<sup>+</sup>) in BM from a normal human donor. (B) Representative FACS profiles of immature myeloid cells in peripheral blood (live leukocyte gate) from a normal donor and a lung cancer patient. (C) Immature myeloid cells (CD11b<sup>+</sup>CD33<sup>+</sup>) expressing CD79a in normal donors and lung cancer patients as a% of live leukocytes. Results are mean +/− SEM (n = 5). (D) Histogram showing proportion of CD79a+ myeloid cells relative to total myeloid cells. Results are mean +/− SEM (n = 5) (E) Representative immunofluorescence staining of infiltrating CD79a<sup>+</sup> myeloid cells in a human invasive breast carcinoma. Scale bar; 20 µm.</p
<p>. The high expression of CD169 (<i>SIGLEC1</i>) by myeloid cells in the arrays was confirmed by a...
<p>Panel A (upper left): a typical example of gating of low, intermediate (Int.) and high complexity...
CD7-positive acute myeloid leukaemias(CD7+AML) represent a distinct biological and clinical subty...
<p>CD79a/b expression on the Ly6C<sup>+</sup> myeloid cell population in multiple tumor models was a...
<p>(A) The effect of stimulation with anti CD79a(v-20) on the migration of FACS-sorted Ly6C+ immatur...
<p>(A) Immunofluorescence of normal lung and metastasis-bearing lungs in the LLC model. Infiltrating...
The CD79 molecule, comprising two polypeptide chains, mb-1 (CD79a) and B29 (CD79b), is physically a...
<p>(A) RNA was extracted from BM cells of naïve SCID mice and from spleen of naïve Balb/c mice and C...
Acute lymphoblastic leukaemia/lymphoma is a malignant disorder derived from the clonal proliferation...
Background: Flow cytometric analysis of leukemias improves accuracy for distinguishing acute leukemi...
<p><b>Copyright information:</b></p><p>Taken from "Composite Multifocal Basal Cell carcinoma and Pre...
<p>A, RT-PCR showed that CD79A and CD79B were detected in human cancer cell lines, U-2 OS, HT-29, He...
We estimated by quantitative flow cytometry (FC) the expression of CD13, CD33, CD34 and CD117 antige...
<p>(A) The ability of tumor cells of varying metastatic potential to induce expression of CD79a on i...
<p>(A+B) The percentage of cells expressing CD73 was high within the T cell subsets but low within t...
<p>. The high expression of CD169 (<i>SIGLEC1</i>) by myeloid cells in the arrays was confirmed by a...
<p>Panel A (upper left): a typical example of gating of low, intermediate (Int.) and high complexity...
CD7-positive acute myeloid leukaemias(CD7+AML) represent a distinct biological and clinical subty...
<p>CD79a/b expression on the Ly6C<sup>+</sup> myeloid cell population in multiple tumor models was a...
<p>(A) The effect of stimulation with anti CD79a(v-20) on the migration of FACS-sorted Ly6C+ immatur...
<p>(A) Immunofluorescence of normal lung and metastasis-bearing lungs in the LLC model. Infiltrating...
The CD79 molecule, comprising two polypeptide chains, mb-1 (CD79a) and B29 (CD79b), is physically a...
<p>(A) RNA was extracted from BM cells of naïve SCID mice and from spleen of naïve Balb/c mice and C...
Acute lymphoblastic leukaemia/lymphoma is a malignant disorder derived from the clonal proliferation...
Background: Flow cytometric analysis of leukemias improves accuracy for distinguishing acute leukemi...
<p><b>Copyright information:</b></p><p>Taken from "Composite Multifocal Basal Cell carcinoma and Pre...
<p>A, RT-PCR showed that CD79A and CD79B were detected in human cancer cell lines, U-2 OS, HT-29, He...
We estimated by quantitative flow cytometry (FC) the expression of CD13, CD33, CD34 and CD117 antige...
<p>(A) The ability of tumor cells of varying metastatic potential to induce expression of CD79a on i...
<p>(A+B) The percentage of cells expressing CD73 was high within the T cell subsets but low within t...
<p>. The high expression of CD169 (<i>SIGLEC1</i>) by myeloid cells in the arrays was confirmed by a...
<p>Panel A (upper left): a typical example of gating of low, intermediate (Int.) and high complexity...
CD7-positive acute myeloid leukaemias(CD7+AML) represent a distinct biological and clinical subty...